Combination of OLMesartan and CCB or Low Dose Diuretics in High Risk Elderly Hypertensive Patients Study (COLM-Study)
Status:
Completed
Trial end date:
2011-09-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to investigate which combination therapy is more effective in
reducing the incidence of cardiovascular events in Japanese elderly high-risk hypertensive
patients: AT1 subtype angiotensin II receptor antagonist/calcium channel blocker or AT1
subtype angiotensin II receptor antagonist/low dose diuretic.
Phase:
Phase 4
Details
Lead Sponsor:
COLM Study Research Organization
Collaborator:
Japan Heart Foundation
Treatments:
Amlodipine Angiotensin II Angiotensin II Type 1 Receptor Blockers Angiotensin Receptor Antagonists Angiotensinogen Calcium Channel Blockers Calcium, Dietary Diuretics Olmesartan Olmesartan Medoxomil